Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cataliotti

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|September 19, 2002
Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCISN Bijker, J L Peterse, I S Fentiman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2010
The impact of young age on breast cancer outcomeL Livi, I Meattini, C Saieva, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2010
The impact of young age on breast cancer outcomeL Livi, I Meattini, C Saieva, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2013
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapyS Zurrida, V Bagnardi, G Curigliano, et al.
Journal of Chemotherapy (Florence, Italy)|November 26, 2009
Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancerL Livi, C Saieva, S Borghesi, et al.
Journal of Chemotherapy (Florence, Italy)|May 4, 2010
Adjuvant trastuzumab in breast cancer: experience from the University of FlorenceL Livi, S Borghesi, I Meattini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2005
The management of elderly patients with T1-T2 breast cancer treated with or without radiotherapyL Livi, F Paiar, E Meldolesi, et al.
Journal of Chemotherapy (Florence, Italy)|April 13, 2011
Use of doxorubicin plus cyclophosphamide followed by docetaxel as adjuvant chemotherapy for breast cancerL Livi, I Meattini, C de Luca Cardillo, et al.
Minerva Chirurgica|November 18, 2010
Postmastectomy radiotherapy in breast cancer adjuvant treatmentL Livi, I Meattini, V Di Cataldo, et al.
Endocrine-Related Cancer|May 28, 2004
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissueC Orlando, C Casini Raggi, S Bianchi, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|September 19, 2002
Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCISN Bijker, J L Peterse, I S Fentiman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2010
The impact of young age on breast cancer outcomeL Livi, I Meattini, C Saieva, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2010
The impact of young age on breast cancer outcomeL Livi, I Meattini, C Saieva, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2013
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapyS Zurrida, V Bagnardi, G Curigliano, et al.
Journal of Chemotherapy (Florence, Italy)|November 26, 2009
Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancerL Livi, C Saieva, S Borghesi, et al.
Journal of Chemotherapy (Florence, Italy)|May 4, 2010
Adjuvant trastuzumab in breast cancer: experience from the University of FlorenceL Livi, S Borghesi, I Meattini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2005
The management of elderly patients with T1-T2 breast cancer treated with or without radiotherapyL Livi, F Paiar, E Meldolesi, et al.
Journal of Chemotherapy (Florence, Italy)|April 13, 2011
Use of doxorubicin plus cyclophosphamide followed by docetaxel as adjuvant chemotherapy for breast cancerL Livi, I Meattini, C de Luca Cardillo, et al.
Minerva Chirurgica|November 18, 2010
Postmastectomy radiotherapy in breast cancer adjuvant treatmentL Livi, I Meattini, V Di Cataldo, et al.
Endocrine-Related Cancer|May 28, 2004
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissueC Orlando, C Casini Raggi, S Bianchi, et al.
Pageof 8